124 algorithm-development-"Prof"-"Washington-University-in-St"-"Prof" positions at Loughborough University
Sort by
Refine Your Search
-
Listed
-
Category
-
Field
-
develop your personal and professional skills. Our benefits include: Good annual leave allowance - 36 days (inclusive of Bank Holidays & University closure days) Competitive pension schemes Fantastic range
-
a supportive and friendly environment with lots of opportunity to learn and develop your personal and professional skills. Our benefits include: Good annual leave allowance - 36 days (inclusive
-
curate networks spanning the 15 Partner Universities, alongside a dedicated team, to jointly realise the aims and ambitions of this important initiative. The post holder will develop and implement
-
technical staff you will be driving the team forward, striving for sporting success, clinical excellence and athlete development. The successful candidate will be experienced in injury assessment
-
2,100 professionals within these. Membership is also open to FE and international institutions. CUBO supports its members with networking, insights, best practice and professional development. CUBO is
-
and Loughborough Business School also holds triple accreditation from AMBA, EQUIS and AACSB. Our position within the higher education sector has been developed by our excellence driven approach and a
-
environments, easy access to a large variety of information resources, and support for the development of information literacy, academic and research skills. This role supports the user experience by providing
-
to develop a high-quality pedagogy that ensures the programme is delivered to a high standard. We are looking for a trained architect, ideally professionally qualified, with practical experience of working in
-
with all food production, including special events and functions, assisting in the development of new dishes and menus, and the provision of general kitchen support. Successful candidates should
-
project, led by Dr. Amanda Pearce at Loughborough University, aims to develop polymer vesicles for site-specific delivery of CRISPR/Cas9 to the brain as a novel therapy for Alzheimer’s Disease (AD